SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-16-011228
Filing Date
2016-02-26
Accepted
2016-02-26 08:22:15
Documents
6
Period of Report
2016-02-26

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT pre14a0216_oxysure.htm PRE 14A 233321
2 GRAPHIC image_005.jpg GRAPHIC 4080
3 GRAPHIC image_001.jpg GRAPHIC 628
4 GRAPHIC image_002.jpg GRAPHIC 707
5 GRAPHIC image_003.jpg GRAPHIC 705
6 GRAPHIC image_004.jpg GRAPHIC 776
  Complete submission text file 0001213900-16-011228.txt   244638
Mailing Address 10880 JOHN W. ELLIOTT ROAD SUITE 600 Frisco TX 75034
Business Address 10880 JOHN W. ELLIOTT ROAD SUITE 600 Frisco TX 75034 (972) 294-6450
OxySure Therapeutics, Inc. (Filer) CIK: 0001413797 (see all company filings)

IRS No.: 710960725 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-54137 | Film No.: 161458015
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10